APA (7th ed.) Citation

Allard, P. N., Alhaj, N., Lobitz, S., Cario, H., Jarisch, A., Grosse, R., . . . Kunz, J. (2022). Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea. Haematologica, 107(7), . https://doi.org/10.3324/haematol.2021.278952

Chicago Style (17th ed.) Citation

Allard, Pierre Nicolas, et al. "Genetic Modifiers of Fetal Hemoglobin Affect the Course of Sickle Cell Disease in Patients Treated with Hydroxyurea." Haematologica 107, no. 7 (2022). https://doi.org/10.3324/haematol.2021.278952.

MLA (9th ed.) Citation

Allard, Pierre Nicolas, et al. "Genetic Modifiers of Fetal Hemoglobin Affect the Course of Sickle Cell Disease in Patients Treated with Hydroxyurea." Haematologica, vol. 107, no. 7, 2022, https://doi.org/10.3324/haematol.2021.278952.